Introduction
Glucokinase (GK) gene expression is essential for glucose homoeostasis. This high& hexokinase is expressed in both the liver and pancreatic P-cell [l-31, as well as in other rare neuraVneuroendocrine cell types that may also play a role in the regulation of glucose homoeostasis [4, 5] . In humans, coding sequence mutations in the GK gene cause maturity-onset diabetes of the young, type 2 (MODY-2), a form of non-insulin-dependent diabetes mellitus [6-81. Since MODY-2 is inherited as an autosoma1 dominant heterozygous trait, its pathogenesis is thought to be due to reduced GK activity from the loss of one functional gene copy Magnuson, unpublished work) . By plotting the average blood glucose concentrations in these different mouse models, the relationship between GK gene dosage and blood glucose concentration becomes evident, as shown in Figure  1 . Interestingly, the relationship appears nonlinear. There is a large difference between zero and one gene copy (in fact, lethal compared with survival), whereas increasing the gene copy number past two has a lesser incremental effect.
Mouse models of altered GK gene copy number
Although these results clearly demonstrate that alterations in GK gene copy number directly affect the blood glucose concentration, they also suggest that the mechanisms involved are likely to be complex.
When bred to homozygosity, these different GK gene mutations are lethal both at mid-gesta- GK gene copy number tion [12] and in the neonatal period [13, 14] . The basis for the differences in the time of lethality is not understood. Indeed, it is surprising that such different results were obtained given that two of the mutations introduced were very similar [12,13]. Nonetheless, when we crossed the GK gene locus transgene into the mice of Bali et al. [12] , the GK null lethality was rescued (K. D. 
Metabolic effects of reduced GK gene copy number
To investigate the effect of decreased GK gene copy number on whole-body glucose metabolism, Bali et al.
[ 121 used metabolic tracer techniques and observed a marked decrease in glucose turnover rates under hyperglycaemic clamp conditions. Although it was not possible in their experiments to determine directly the relative contributions of the liver and islet to the wholebody turnover defect, the mice appeared to have both an insulin-secretory defect and a defect in hepatic glucose metabolism [ 121. In contrast, Grupe et al. [13] used a transgene that expressed GK in the islet to rescue the neonatal lethality observed in their GK knock-out mice, thereby concluding that it was possible for the mice to live without hepatic GK, although these animals remained markedly hyperglycaemic [ 131.
Although the results generated by both Terauchi et al. [14] and Grupe et al. [13] clearly demonstrate a critical function for GK in the islet, without glucose-turnover data the effect of these mutations on hepatic glucose metabolism are less apparent. Magnuson, unpublished work) . This apparent paradox is explained by the powerful influence of glucose on the islet: hypoglycaemia reduces the amount of islet GK [18-201. Since the islet contributes little to the hypoglycaemia in these mice, the liver is implicated as the chief determinant of the lower blood glucose concentration in the context of increased GK gene copy number. As discussed below, the downregulation of islet GI( by hypoglycaemia agpears to be an acqtive response that prevents a more severe hypoglycaemia phenotype.
Effects of increased GK gene copy number

Dual role of GK in glucose homoeostasis
Both the GK gene knock-out and GK gene locus transgenic mouse models provide further support for an essential role of both islet and hepatic GK in glucose homoeostasis. The role of diminished islet GK in the pathogenesis of MODY-2 is clear: decreased islet GK activity causes impaired glucose-stimulated insulin secretion [7, 21] Magnuson, unpublished work) and in the GK gene knock-out mice of Bali et al. [12] , although by different mechanisms, the observed differences in whole-body glucose metabolism can be attributed to the difference in hepatic GK activities in these two models, as illustrated in Figure  2 . In further support of a metabolic defect in the liver, the studies of Bali et al. [12] also revealed defective suppression of hepatic glucose production by hyperglycaemia in heterozygous knockout mice, although the precise nature of this defect is similarly confounded by the lower insulin levels in the GK knock-out mice. In MODY-2 patients, Velho et al. [22] have detected an impairment in hepatic glycogen synthesis by C-NMR spectroscopy, again implicating hepatic GK in the pathogenesis of this disease. Thus diminished islet GK raises the set point for glucose-stimulated insulin secretion, and diminished hepatic GK activity lowers the efficiency of hepatic glucose metabolism. Both of these defects conspire to raise the blood glucose concentration.
The function and regulation of GK in the liver is more complex than it is in the islet. Depending on the hormonal milieu, the liver can either be a net consumer of glucose, as in the fed condition, or a net producer of glucose, such as during fasting [23, 24] . Whereas many hepatic enzymes are co-ordinately regulated to enable this metabolic shift, net glucose-phosphorylating Because the p-cell insulin-secretory defects were similar in these two different models, the differences in whole-body glucose turnover can be attributed to changes in GK activity in the liver, thereby revealing the role of hepatic GK in whole-body glucose metabolism. +/+, Control: +/-, GK heterozygous knockout: Tg, GK transgenic.
A hepltlc QK activity activity is determined by the combination of gene transcription, inhibitory interactions with GK regulatory protein (GKRP), the activity of glucose-6-phosphatase (the opposing enzyme in the substrate cycle), and various substrate concentrations determine the net rate of glucose phosphorylation [24, 25] . In addition, GK also appears to play a role in the regulation of gene transcription by glucose in the liver. For instance, transcription of the L-type pyruvate kinase [26] , fatty acid synthase [27] and glucose-6-phosphatase [28] genes are all affected to some extent by glycolytic flux in the liver, the initial rate of which is dependent on GK. Thus, besides affecting glucose utilization by the liver, diminished GK gene copy number may also alter the regulation of other hepatic genes involved in glucose homoeostasis.
Mechanisms affecting GK activity in vivo
It has previously been noted that the loss of a single GK gene copy has relatively little effect on the plasma glucose concentration, leading to the suggestion that compensatory mechanisms may exist [29] . Analysis of these various mouse models suggests that the blood glucose concentration itself may be involved in some of these mechanisms. The hyperglycaemia that results from diminished GK gene copy number appears to act on both the islet and hepatocyte to compensate partially for the decrease in gene dosage, as shown in Figure 3@ ). The mechanism(s) involved remains unclear, but one explanation is that glucose directly affects the stability of GK in both the liver and islet. In addition, hyperglycaemia may enhance the dissociation of GK from GKRP [30, 31] in the hepatocyte. Together, all of these responses probably help compensate for the loss of one functional GK gene copy. The same mechanisms that help compensate for diminished GK gene copy number probably also protect against the effect of excess GK, as shown in Figure 3 Possible modulatory effects of glucose on GK activity in the liver and /I-cell (A) In the situation of reduced GK gene copy number, the hyperglycaemia that results from diminished insulin secretion from the p-cell and reduced hepatic glucose utilization may be attenuated by increased GK stability in both the hepatocyte and /I-cell. In addition, there may be a reduction in the amount of GK bound to GKRP in the nucleus (shaded region), which would probably increase the net hepatic GK activity. Combined, these responses lead to a lower degree of hyperglycaemia than might be expected in the face of the loss of one GK gene copy. (6) In the situation of increased GK gene copy number, the hypoglycaemia that results from increased hepatic GK activity and increased efficiency of hepatic glucose utilization leads to diminished islet GK activity and diminished insulin secretion. However, the extent of the hypoglycaemia may be attenuated by increased binding of GK to GKRP in the nucleus, the net effect of which would be less cytosolic GK and less hepatic glucose uptake. These possible modulatory effects of glucose on GK activity, both in the hepatocyte and p-cell, which have been suggested by the studies of mice with altered GK gene copy number, remain to be further elucidated.
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Reduced GK gene copy number Increased GK gene copy number VstabiliJ Hepatocyte p cell thereby inhibiting the enzyme [30,32-341. The increased binding of GK to GKRP, perhaps in response to hypoglycaemia, would also be expected to safeguard against a more severe hypoglycaemic phenotype. All of these mechanisms may be essential for maintaining islet and hepatic GK activities within an optimal physiological range. Indeed, it is not surprising that multiple mechanisms exist to regulate GK activity precisely in the liver and islet given the profound influence that this enzyme has on insulin secretion from the P-cell and on glucose utilization and intermediary metabolism in the liver.
Conclusions
The role of GK in glucose homoeostasis is complex and involves multiple tissues. Although recent studies have addressed the role of GK in the pancreatic islet and liver, its role in extrapancreatic neuroendocrine cells and the brain remains to be determined. Indeed, it is likely that the effects of GK are not just dual (e.g. liver and islet), but multiple, probably also involving the secretion of glucoincretins and neurally mediated responses such as hypoglycaemiainduced counter-regulation. These regulatory networks and feedback loops, all of which are involved in glucose homoeostasis, are best studied in the whole animal. Thus further studies of the tissue-specific function and regulation of GK using gene-altered mice should fully elucidate the role of this enzyme in glucose homoeostasis and diabetes.
